You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Obesity

Tirzepatide for managing overweight and obesity

  • Technology appraisal guidance
  • Reference number: TA1026
  • Published:  23 December 2024
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Summary versions
  2. Education
  3. Case studies
  4. Implementation support
  5. Resource impact
  6. Guidance into practice

Tools and resources

Tools and resources to help you put the guidance into practice.

Summary versions

  • Visual summary: Principles of care  (PDF 102 KB)

    Published:
    23 June 2025
  • Visual summary: The potential care journey  (PDF 120 KB)

    Published:
    23 June 2025

Education

  • Tirzepatide: a discussion aid for healthcare professionals and patients (PDF 714 KB)

    Published:
    28 May 2025

Case studies

  • Injectable anti-obesity medications in specialist weight management services: supporting people with complex needs

Implementation support

  • A practical guide to using medicines to manage overweight and obesity

  • Initial assessment before prescribing tirzepatide - checklist (Word 34 KB)

    Published:
    19 March 2025
  • Counselling before prescribing tirzepatide - checklist (Word 35 KB)

    Published:
    19 March 2025
  • Follow up and monitoring when prescribing tirzepatide - checklist (Word 35 KB)

    Published:
    19 March 2025
  • Tirzepatide: local formulary information

Resource impact

  • Resource impact template (Excel 2.38 MB)

    Published:
    11 July 2025
  • Resource impact template and summary report

  • Resource impact summary report

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top